美国公司KKR提出12亿美元买断瑞典公司Biotage, 提供60%的溢价。 US firm KKR proposes $1.2 billion buyout of Swedish firm Biotage, offering a 60% premium.

美国投资公司KKR正在提供12亿美元来购买一家瑞典生命科学公司Biotage,该公司的价值约为12.2亿美元。 US investment firm KKR is offering $1.2 billion to acquire Biotage, a Swedish life-sciences company, which values the firm at about $1.22 billion. KKR 已经通过 Gamma Biosciences 拥有 Biotage 17% 的股份，并提议以较近期股价溢价 60% 的价格收购该公司的其余部分。 KKR, already owning 17% of Biotage through Gamma Biosciences, is proposing to buy out the rest of the company at a 60% premium to its recent share price. 生物群董事会建议股东接受报价。 Biotage's board recommends that shareholders accept the offer.